申请人:Rogers Bruce Nelsen
公开号:US20080132551A1
公开(公告)日:2008-06-05
The invention provides compounds of Formula I:
wherein A, B, and X are described herein. These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals used to treat diseases or conditions in which α7 nAChR is known to be involved.
本发明提供了I式化合物:其中A、B和X在此处描述。这些化合物可以是药物盐或组合物的形式,可以是纯对映体形式或混合物,可用于制备药物,用于治疗已知α7 nAChR参与的疾病或病症。